Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Shanghai Junshi Biosciences Co (OTCPK:SHJBF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Shanghai Junshi Biosciences Co's EV-to-EBIT for today is
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai Junshi Biosciences Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-128.2 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Shanghai Junshi Biosciences Co's EV-to-EBITDA for today is:
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai Junshi Biosciences Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-128.2 Mil.
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai Junshi Biosciences Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $351.6 Mil.
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai Junshi Biosciences Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $-72.1 Mil.
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Shanghai Junshi Biosciences Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-180.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Junshi Biosciences Co Enterprise Value Related Terms
Shanghai Junshi Biosciences Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Junshi Biosciences Co Enterprise Value Chart
SHJBF vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Junshi Biosciences Co Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Shanghai Junshi Biosciences Co's Enterprise Value falls into.
Shanghai Junshi Biosciences Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of $4,738.9 Mil mean?
Shanghai Junshi Biosciences Co (SHJBF) has a Enterprise Value of $4,738.9 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Shanghai Junshi Biosciences Co and its competitors.
Is Shanghai Junshi Biosciences Co's Enterprise Value too high?
Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Enterprise Value compare to VRTX and REGN?
Shanghai Junshi Biosciences Co's Enterprise Value of $4,738.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Shanghai Junshi Biosciences Co and its competitors. Shanghai Junshi Biosciences Co's current Enterprise Value is $4,738.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (SHJBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $5.63, compared to a current price of $3.35 — trading 40.5% below its estimated fair value. The current Enterprise Value is $4,738.9 Mil. Shanghai Junshi Biosciences Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current Enterprise Value is $4,738.9 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued.
The current stock price of $3.35 is trading 40.5% below its estimated GF Value™ of $5.63.
GuruFocus considers Shanghai Junshi Biosciences Co to be Significantly Undervalued.
Key valuation signals for SHJBF:
Enterprise Value: $4,738.9 Mil
GF Value™: $5.63 vs. price of $3.35 (40.5% below fair value)
No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Junshi Biosciences Co Business Description
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
66GF Score
Get the complete analysis for SHJBF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHJBF has been successfully added to your 
